| SC 13D/A | 2024-03-29 | RA CAPITAL MANAGEMENT, L.P. | ARS Pharmaceuticals, Inc. | 10,860,977 | 11.3% | EDGAR |
| SC 13G/A | 2024-02-09 | FMR LLC | ARS Pharmaceuticals, Inc. | 1,202,315 | 1.3% | EDGAR |
| SC 13D/A | 2023-09-25 | RA CAPITAL MANAGEMENT, L.P. | ARS Pharmaceuticals, Inc. | 9,459,678 | 9.9% | EDGAR |
| SC 13D/A | 2023-09-01 | Bell Robert G. | ARS Pharmaceuticals, Inc. | 4,313,965 | 4.5% | EDGAR |
| SC 13D | 2023-08-31 | RA CAPITAL MANAGEMENT, L.P. | ARS Pharmaceuticals, Inc. | 6,759,678 | 7.1% | EDGAR |
| SC 13G/A | 2023-02-14 | NEXTECH VI ONCOLOGY SCSP | ARS Pharmaceuticals, Inc. | 1,910,029 | 2.0% | EDGAR |
| SC 13G/A | 2023-02-13 | K2 PRINCIPAL FUND, L.P. | ARS Pharmaceuticals, Inc. | 2,045,348 | 2.2% | EDGAR |
| SC 13G/A | 2023-02-09 | FMR LLC | ARS Pharmaceuticals, Inc. | 5,369,362 | 5.7% | EDGAR |
| SC 13D/A | 2022-11-30 | ORBIMED ADVISORS LLC | ARS Pharmaceuticals, Inc. | 7,788,510 | 8.3% | EDGAR |
| SC 13D | 2022-11-21 | Bell Robert G. | ARS Pharmaceuticals, Inc. | 8,563,965 | 9.1% | EDGAR |
| SC 13D | 2022-11-18 | Tanimoto Sarina | ARS Pharmaceuticals, Inc. | 6,265,170 | 6.7% | EDGAR |
| SC 13D | 2022-11-18 | Lowenthal Richard E | ARS Pharmaceuticals, Inc. | 7,422,432 | 7.9% | EDGAR |
| SC 13D | 2022-11-18 | Pratik Shah Living Trust dated June 15, 2011 | ARS Pharmaceuticals, Inc. | 10,156,204 | 10.8% | EDGAR |
| SC 13D | 2022-11-18 | Flynn James E | ARS Pharmaceuticals, Inc. | 5,538,964 | 5.9% | EDGAR |
| SC 13G | 2022-07-18 | K2 PRINCIPAL FUND, L.P. | Silverback Therapeutics, Inc. | 1,906,618 | 5.4% | EDGAR |
| SC 13G/A | 2022-02-14 | EcoR1 Capital, LLC | Silverback Therapeutics, Inc. | 1,060,010 | 3.0% | EDGAR |
| SC 13G/A | 2022-02-14 | RA CAPITAL MANAGEMENT, L.P. | Silverback Therapeutics, Inc. | 1,742,186 | 5.0% | EDGAR |
| SC 13G/A | 2022-02-14 | Boxer Capital, LLC | Silverback Therapeutics, Inc. | - | 0.0% | EDGAR |
| SC 13G | 2022-02-11 | WASATCH ADVISORS INC | Silverback Therapeutics, Inc. | - | - | EDGAR |
| SC 13G/A | 2022-02-09 | FMR LLC | Silverback Therapeutics, Inc. | 3,753,737 | 10.7% | EDGAR |